cas 187949-02-6|| where to buy 7-Chloro-3-((2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl)quinazolin-4(3H)-one

Nom du produit:7-Chloro-3-((2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl)quinazolin-4(3H)-one

IUPAC Name:7-chloro-3-[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1H-1,2,4-triazol-1-yl)butan-2-yl]-3,4-dihydroquinazolin-4-one

: CAS：187949-02-6; Formule moléculaire：C20H16ClF2N5O2; Pureté：97%

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM212540-1g	1-2 Weeks	Ǡşǆœ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 187949-02-6 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:187949-02-6; Formule moléculaire:C20H16ClF2N5O2; Point de fusion:-; Code SMILES:ClC1=CC2=C(C(N(C=N2)[C@@H]([C@@](O)(C3=C(C=C(F)C=C3)F)CN4N=CN=C4)C)=O)C=C1; Densité:

: Numéro de catalogue:CM212540; Poids moléculaire:431.83; Point d'ébullition:; N° Mdl:MFCD09837823; Stockage:

: Quinazolines; Quinazolines belong to heterocyclic chemistry, also known as 1,3-naphthalenes. The backbone consists of two six-membered aromatic rings fused to each other, with two nitrogen atoms at positions 1 and 3 on the backbone. The presence of these two nitrogen atoms in quinazoline increases its importance in pharmaceutical and biological reactions. Quinazolines and their derivatives are among the most important heterocyclic compounds due to their diverse chemical reactivity and important range of biological activities.

: Triazoles; Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.